Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Typhoid Vaccine

Typhoid Vaccine

Typhoid Vaccine: A Comprehensive Guide to Prevention, Types, and Effectiveness

Typhoid fever, caused by the bacterium Salmonella enterica serotype Typhi, remains a major public health concern in many parts of the world, particularly in developing countries with poor sanitation and hygiene. Every year, millions of people are affected by this potentially deadly disease, with symptoms ranging from high fever, abdominal pain, and weakness to more severe complications like intestinal bleeding and perforation. One of the most effective ways to prevent typhoid fever is through vaccination.

What is Typhoid Fever?

Typhoid fever is a systemic infection caused by the bacterium Salmonella Typhi. The bacteria are primarily spread through contaminated food and water, usually as a result of poor sanitation practices. Once ingested, Salmonella Typhi colonizes the intestines and can spread to the bloodstream, causing systemic illness.

The hallmark symptoms of typhoid fever include:

  • High fever (often peaking around 103–104°F or 39–40°C)

  • Abdominal pain

  • Headache

  • Weakness and fatigue

  • Loss of appetite

  • Rash (rose-colored spots on the abdomen in some cases)

  • Diarrhea or constipation

If left untreated, the infection can lead to severe complications like intestinal perforation (a hole in the intestine), which can lead to peritonitis (inflammation of the abdominal lining), sepsis, and even death. Antibiotics are commonly used to treat the infection, but the rise of antibiotic resistance has complicated treatment, making prevention even more important.

Typhoid Fever Global Burden

Typhoid fever is a significant health issue in many parts of the world, particularly in low- and middle-income countries where water and sanitation infrastructure are inadequate. The World Health Organization (WHO) estimates that there are approximately 11–20 million cases of typhoid fever globally each year, leading to around 128,000–161,000 deaths annually. The majority of these cases occur in regions of South Asia, Africa, and parts of Latin America.

Although typhoid fever has been largely controlled in high-income countries through improved sanitation and the availability of antibiotics, it remains a pressing concern in areas with poor access to clean water, healthcare, and sanitation. Vaccination, alongside improvements in sanitation and hygiene, is critical in controlling the spread of the disease.

The Role of Vaccination in Preventing Typhoid Fever

Vaccination is one of the most effective ways to prevent typhoid fever, particularly in areas where the disease is endemic. Typhoid vaccines stimulate the immune system to recognize and fight Salmonella Typhi bacteria, reducing the risk of infection if a person is exposed to the bacteria. The vaccines are especially important for individuals who are at higher risk, including:

  • Travelers to regions where typhoid fever is endemic

  • Children living in areas with high incidence of typhoid

  • People working in healthcare settings or those in direct contact with contaminated water sources

Types of Typhoid Vaccines

There are two main types of Typhoid vaccines: the injectable Vi polysaccharide vaccine and the oral live attenuated vaccine. Both vaccines are designed to prevent typhoid fever, but they work in different ways and are administered through different routes.

1. Injectable Vi Polysaccharide Vaccine (ViPS)

The Vi polysaccharide vaccine (ViPS) is an inactivated (killed) vaccine, meaning it contains a non-living version of the bacteria. It is made from the Vi antigen, a component of the Salmonella Typhi bacteria's outer surface. The vaccine works by stimulating the immune system to produce antibodies against the Vi antigen, preparing the body to fight the bacteria if exposed in the future.

How It Works:

  • The vaccine is administered as an injection into the muscle or under the skin.

  • It stimulates the immune system to recognize and respond to Salmonella Typhi.

  • It provides immunity by triggering the production of antibodies that protect the body from infection.

Effectiveness:

  • The ViPS vaccine is effective in approximately 50–80% of individuals who receive the vaccine, offering protection for about 2–3 years.

  • The protection is strongest in individuals who have been vaccinated prior to exposure to the bacteria.

Who Should Get the ViPS Vaccine:

  • It is recommended for travelers to endemic areas where typhoid fever is common.

  • The ViPS vaccine is generally administered to individuals over 2 years old and is a single-dose vaccine.

Advantages of ViPS:

  • One-time dose, making it easy for travelers and people in endemic areas to get vaccinated.

  • Fewer contraindications compared to the oral vaccine.

Limitations of ViPS:

  • Shorter duration of immunity compared to the oral vaccine (requires a booster after 2–3 years).

  • It may not be as effective in young children.

2. Oral Typhoid Vaccine (Ty21a)

The oral live attenuated vaccine (Ty21a) is made from a weakened (but live) version of Salmonella Typhi. The bacteria in this vaccine are modified to make them less harmful while still stimulating the immune system to produce a response. The vaccine is typically taken in a series of capsules.

How It Works:

  • The oral vaccine is taken in 4 doses, with each capsule taken every other day.

  • It works by stimulating both humoral (antibody-mediated) and cell-mediated immunity, providing robust protection against typhoid fever.

  • Once ingested, the live bacteria stimulate the immune system to recognize Salmonella Typhi and produce protective antibodies.

Effectiveness:

  • The Ty21a vaccine is effective in 50–80% of individuals.

  • The protection lasts for approximately 5 years, which is longer than the ViPS vaccine.

Who Should Get the Oral Vaccine:

  • It is recommended for travelers to regions where typhoid fever is endemic.

  • The vaccine is typically used in children over 6 years of age.

Advantages of Ty21a:

  • Longer duration of immunity compared to ViPS (up to 5 years).

  • Oral administration makes it suitable for individuals who are averse to injections.

Limitations of Ty21a:

  • Requires multiple doses (4 capsules), which may be challenging for some individuals to complete.

  • Can cause mild gastrointestinal symptoms like nausea or stomach discomfort.

3. Combination Vaccines

There are also combination vaccines available, particularly in countries where multiple vaccines are needed to protect against a range of diseases. These vaccines combine the typhoid vaccine with other vaccines, such as the Hepatitis A vaccine, to provide broader protection.

The Safety of Typhoid Vaccines

Typhoid vaccines are generally safe, and most people tolerate them well. However, like all vaccines, they can cause mild side effects in some individuals. These side effects are typically temporary and go away on their own.

Common Side Effects of Typhoid Vaccines:

Injectable Vi Polysaccharide Vaccine (ViPS):

  • Pain, redness, or swelling at the injection site.

  • Mild fever.

  • Fatigue or malaise.

Oral Typhoid Vaccine (Ty21a):

  • Mild nausea or stomach discomfort.

  • Diarrhea.

  • Headache.

Serious side effects are rare but can include allergic reactions. It is important to consult a healthcare provider before receiving the vaccine, especially for individuals who are pregnant, immunocompromised, or have a history of severe allergic reactions.

Who Should Get Vaccinated?

The typhoid vaccine is recommended for individuals who are at increased risk of infection, including:

  1. Travelers to areas where typhoid fever is common, particularly South Asia, parts of Africa, and Latin America.

  2. Children living in endemic areas who are at higher risk of contracting typhoid fever due to environmental factors.

  3. Individuals working in healthcare settings or jobs where they may come into contact with contaminated water or food.

It is important to get vaccinated before traveling to endemic regions, ideally at least two weeks before departure, to ensure the vaccine has time to take effect.

Typhoid Vaccine and Public Health

The introduction of typhoid vaccines has had a significant impact on controlling the spread of typhoid fever, particularly in regions where the disease is endemic. Vaccination campaigns have been successful in reducing the incidence of typhoid fever in countries like India, Pakistan, and Vietnam.

In addition to vaccination, improving sanitation and safe drinking water access are key components of reducing the burden of typhoid fever in these regions. The combined approach of vaccination and improving hygiene and infrastructure has been shown to dramatically reduce the incidence of the disease and prevent outbreaks.

Conclusion

Typhoid fever remains a global health concern, especially in regions with poor sanitation and inadequate access to clean water. However, typhoid vaccines have proven to be an essential tool in preventing this potentially deadly disease. The availability of both injectable and oral vaccines provides individuals with choices depending on their preferences and the specific health conditions.

Avaiable Medicines